Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition.
Saved in:
| Title: | Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition. |
|---|---|
| Authors: | Ringnalda FCAS; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Son GJF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Verweij LHG; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Kim SY; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Amo-Addae V; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Flucke UE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Hiemcke-Jiwa LS; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Langenberg KPS; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Bramer JAM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Heimans L; Sarcomas and GIST Center, Netherlands Cancer Institute-Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, The Netherlands., van de Sande MAJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Houdt WJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, The Netherlands., van Noesel MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kerstens HHD; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Santoso M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Seifert G; Department of Pediatrics, Division of Oncology and Hematology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Delattre O; Institut Curie Research Center, NSERM U1330, Diversity and Plasticity of Pediatric Sarcoma Lab, PSL Research University, SIREDO Oncology Center, Paris, France., Scotlandi K; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Geoerger B; Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Paris, France., Merks JHM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Division of Imaging and Oncology, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Boxtel R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van de Wetering M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Sanders K; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. k.sanders@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, The Netherlands. k.sanders@prinsesmaximacentrum.nl., Clevers H; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. h.clevers@hubrecht.eu.; Oncode Institute, Utrecht, The Netherlands. h.clevers@hubrecht.eu.; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center, Utrecht, The Netherlands. h.clevers@hubrecht.eu.; Pharma, Research and Early Development (pRED) of F. Hoffmann-La Roche Ltd, Basel, Switzerland. h.clevers@hubrecht.eu. |
| Source: | Nature communications [Nat Commun] 2025 Aug 21; Vol. 16 (1), pp. 7689. Date of Electronic Publication: 2025 Aug 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40841360 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ringnalda+FCAS%22">Ringnalda FCAS</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Son+GJF%22">van Son GJF</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Verweij+LHG%22">Verweij LHG</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kim+SY%22">Kim SY</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Amo-Addae+V%22">Amo-Addae V</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Flucke+UE%22">Flucke UE</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hiemcke-Jiwa+LS%22">Hiemcke-Jiwa LS</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Langenberg+KPS%22">Langenberg KPS</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bramer+JAM%22">Bramer JAM</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Heimans+L%22">Heimans L</searchLink>; Sarcomas and GIST Center, Netherlands Cancer Institute-Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+de+Sande+MAJ%22">van de Sande MAJ</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Houdt+WJ%22">van Houdt WJ</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Noesel+MM%22">van Noesel MM</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kerstens+HHD%22">Kerstens HHD</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Santoso+M%22">Santoso M</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Seifert+G%22">Seifert G</searchLink>; Department of Pediatrics, Division of Oncology and Hematology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Delattre+O%22">Delattre O</searchLink>; Institut Curie Research Center, NSERM U1330, Diversity and Plasticity of Pediatric Sarcoma Lab, PSL Research University, SIREDO Oncology Center, Paris, France.<br /><searchLink fieldCode="AU" term="%22Scotlandi+K%22">Scotlandi K</searchLink>; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Geoerger+B%22">Geoerger B</searchLink>; Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Paris, France.<br /><searchLink fieldCode="AU" term="%22Merks+JHM%22">Merks JHM</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Division of Imaging and Oncology, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Molenaar+JJ%22">Molenaar JJ</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Boxtel+R%22">van Boxtel R</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+de+Wetering+M%22">van de Wetering M</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Sanders+K%22">Sanders K</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. k.sanders@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, The Netherlands. k.sanders@prinsesmaximacentrum.nl.<br /><searchLink fieldCode="AU" term="%22Clevers+H%22">Clevers H</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. h.clevers@hubrecht.eu.; Oncode Institute, Utrecht, The Netherlands. h.clevers@hubrecht.eu.; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center, Utrecht, The Netherlands. h.clevers@hubrecht.eu.; Pharma, Research and Early Development (pRED) of F. Hoffmann-La Roche Ltd, Basel, Switzerland. h.clevers@hubrecht.eu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Aug 21; Vol. 16 (1), pp. 7689. <i>Date of Electronic Publication: </i>2025 Aug 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40841360 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-025-62673-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 7689 Titles: – TitleFull: Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ringnalda FCAS – PersonEntity: Name: NameFull: van Son GJF – PersonEntity: Name: NameFull: Verweij LHG – PersonEntity: Name: NameFull: Kim SY – PersonEntity: Name: NameFull: Amo-Addae V – PersonEntity: Name: NameFull: Flucke UE – PersonEntity: Name: NameFull: Hiemcke-Jiwa LS – PersonEntity: Name: NameFull: Langenberg KPS – PersonEntity: Name: NameFull: Bramer JAM – PersonEntity: Name: NameFull: Heimans L – PersonEntity: Name: NameFull: van de Sande MAJ – PersonEntity: Name: NameFull: van Houdt WJ – PersonEntity: Name: NameFull: van Noesel MM – PersonEntity: Name: NameFull: Kerstens HHD – PersonEntity: Name: NameFull: Santoso M – PersonEntity: Name: NameFull: Seifert G – PersonEntity: Name: NameFull: Delattre O – PersonEntity: Name: NameFull: Scotlandi K – PersonEntity: Name: NameFull: Geoerger B – PersonEntity: Name: NameFull: Merks JHM – PersonEntity: Name: NameFull: Molenaar JJ – PersonEntity: Name: NameFull: van Boxtel R – PersonEntity: Name: NameFull: van de Wetering M – PersonEntity: Name: NameFull: Sanders K – PersonEntity: Name: NameFull: Clevers H IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 08 Text: 2025 Aug 21 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 16 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |